Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021
Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021. The company aims to create oral medicines for neurodegenerative disorders using a proprietary platform to identify small molecules targeting RNA structures.
Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021
Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021. The company aims to create oral medicines for neurodegenerative disorders using a proprietary platform to identify small molecules targeting RNA structures.